HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration.

AbstractBACKGROUND:
It has been postulated that soybean isoflavones act as inhibitory factors in prostate cancer. However, to date there have been no case-controlled clinical studies carried out to compare the circulating concentrations of isoflavones in prostate cancer patients and control subjects.
METHODS:
The serum levels of genistein, daidzein and equol were determined and compared in 253 experimental subjects (141 prostate cancer patients and 112 cancer-free controls).
RESULTS:
The serum concentrations of isoflavones were compared in hospitalized and non-hospitalized subjects and for both the prostate cancer patients and the controls the concentrations were lower in the hospitalized subjects. The serum concentrations of genistein and daidzein were compared in subjects <70 years of age and subjects >/=70 years old and the levels were significantly lower in the younger group. Contrary to our expectation, comparison of the patient group and the control group revealed the serum concentrations of isoflavones to be higher in the patient group. Daidzein non-metabolizers were compared in the hospitalized experimental subjects of the patient group and the control group and they were significantly more common in the patient group. The poorly differentiated cancer patient group included a significantly lower percentage of daidzein metabolizers.
CONCLUSIONS:
The above findings revealed that equol itself or some unknown factor regulating the metabolism of daidzein is deeply involved in the biology of prostate cancer. Future studies are urgently needed to compare the incidence of daidzein metabolizers among various countries.
AuthorsHideyuki Akaza, Naoto Miyanaga, Naomi Takashima, Seiji Naito, Yoshihiko Hirao, Taiji Tsukamoto, Mitsuru Mori
JournalJapanese journal of clinical oncology (Jpn J Clin Oncol) Vol. 32 Issue 8 Pg. 296-300 (Aug 2002) ISSN: 0368-2811 [Print] England
PMID12411567 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Isoflavones
  • daidzein
  • Genistein
  • Prostate-Specific Antigen
Topics
  • Aged
  • Case-Control Studies
  • Genistein (blood)
  • Humans
  • Isoflavones (blood, metabolism)
  • Male
  • Prostate-Specific Antigen (blood)
  • Prostatic Neoplasms (blood, diagnosis)
  • Risk
  • Soybeans (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: